2026

Articles
Title
IX BIOPHARMA: OCBC Initiates Coverage, Values Wafermine At Over S$1 Billion
ANALYSTS SAY: Buy, Sell, Hold (26 Oct)
YZJ MARITIME: Why Chairman Ren Yuanlin Is Bullish About Next 8–10 Years
ANALYSTS SAY: Buy, Sell, Hold (23 Oct)
DELUGE: Big Projects First, High-Margin After-Sales For Years
ANALYSTS SAY: Buy, Sell, Hold (22 Oct)
CSE Global: UOBKH Sees More Upside After Management Meeting
ANALYSTS SAY: Buy, Sell, Hold (21 Oct)
YANGZIJIANG: Three Bullish Brokers — DBS Now Has The Highest Target Price
ANALYSTS SAY: Buy, Sell, Hold (20 Oct)